Protective Effects of Thymus schimperi and Moringa stenopetala Leaf Extracts on Arterial Blood Pressure and Urine Protein Level in Pre-eclampsia Rat Models

Main Article Content

Kumlachew Mergiaw
Yoseph A. Mengesha
Tesfaye Tolessa
Eyasu Makonnen
Solomon Genet
Abiy Abebe
Kidist Gebreyesus
Ashenif Tadele
Asfaw Debella
Demeke Ashencho


Background: Pre-eclampsia (PE) is a common hypertensive disorder during pregnancy and one of the leading causes of perinatal mortality and morbidity. There is no curative modern drug to treat PE. Therefore, researches done on traditional medications have paramount importance in discovering therapeutic and /or protective agents from plant materials. In Ethiopia, there are claims that some indigenous medicinal plants such as Thymus and Moringa can have potential protective functions against PE. The aim of this study was to prove the claims.

Methods: Experiments were performed to investigate the effects of aqueous leaf extracts of Thymus schimperi (ALETS) and Moringa stenopetala (ALEMS) on PE rat models induced by nitro-L-arginine methyl ester (L-NAME); a nitric oxide synthase inhibitor. A non-invasive tail cuff blood pressure recorder (Model 179 Amplifier, IITC INC, Life Science Instruments, Woodland Hills, California) was used to determine the arterial blood pressure from rat tail. Urine  analysis  to determine protein levels  was  performed  using  a  dipstick,  semi-qualitative  method  as  per  manufacturer’s instructions (CYBO DFI Korea).

Results: ALETS treated PE rat models showed significantly reduced mean arterial blood pressure (MAP) in mmHg; 108±3 (P<0.05), 105±1 (P<0.01) and 99±2 (P<0.01); also the same pattern of results were seen in ALEMS treated PE groups with MAP of 106±1 (P<0.05), 103±1 (P<0.05) and 101±1 (P<0.05) at daily doses of 250 mg/kg, 500 mg/kg and 1000 mg/kg, respectively, compared to untreated case group that had 123±3.7 mmHg at gestation day (GD) 19 . Untreated PE rat models showed significant proteinuria (2000±20 mg/L) throughout the gestation period; while PE rat models treated with either ALETS or ALEMS had significantly reduced (p<0.05) proteinuria in dose dependent pattern (150±15 mg/L) at a dose of 1 gm/kg for each plant extract at GD 19.

Conclusion: Aqueous leaf extracts of either Thymus schimperi or Moringa stenopetala might reduce and control arterial pressure in PE rat models in a dose dependent manner.  The extracts also could reduce level of proteinuria in the same pattern. Further investigation should, however, be carried out to confirm their uses in prevention and/or treatment of pregnancy-induced hypertension among human cases.

Blood pressure, pre-eclampsia, proteinuria, protective, extract, Thymus schimperi, Moringa stenopetala, rat models

Article Details

How to Cite
Mergiaw, K., Mengesha, Y. A., Tolessa, T., Makonnen, E., Genet, S., Abebe, A., Gebreyesus, K., Tadele, A., Debella, A., & Ashencho, D. (2020). Protective Effects of Thymus schimperi and Moringa stenopetala Leaf Extracts on Arterial Blood Pressure and Urine Protein Level in Pre-eclampsia Rat Models. Cardiology and Angiology: An International Journal, 9(3), 31-37.
Original Research Article


Tesfaye G, Tilahun R. Pregnancy induced hypertension and associated factors among women attending delivery service at Mizan-Tepi University Teaching Hospital, Tepi General Hospital and Gebretsadik Shawo Hospital, Southwest, Ethiopia. Ethiop J Health Sci. 2019;29(1): 831–840.

Mammaro A, Carrara S, Cavaliere A, Cavaliere A, Ermito S, Dinatale A, Pappalardo E, Militello M, Pedata R. Hypertensive disorders of pregnancy. J Prenat Med. 2009;3(1):1‐5.

Harsha S, Deepti S. Assessment of platelet indices in pregnancy induced hypertensive patients versus normotensive pregnant patients. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2019;8(5):1-5.

Powe C, Levine R, Karumanchi S. Preeclampsia, a disease of the maternal endothelium: The role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011; 123(24):2856‐2869.

Marilyn J, Richard P. Seizures in women with preeclampsia: Mechanisms and management. Fetal Matern Med Rev. 2011;22(02):91–108.

Owiredu L, Turpin N. Putative risk factors of pregnancy-induced hypertension among Ghanaian pregnant women. Journal of Medical and Biomedical Sciences. 2012; 1(3):62-76.

Coppage K, Sibai B. Preeclampsia and eclampsia. Women's Med. 2008;1(1): 1756-2228.

Andrea G, Vesna D. The management of hypertension in pregnancy. Adv Chronic Kidney Dis. 2013;20(3):229–239.

Arun J. Epidemiology of preeclampsia: Impact of obesity. Nutr Rev. 2013;71(1):1-4.

Gathiram P, Moodley J. Pre-eclampsia: Its pathogenesis and pathophysiology. Cardiovascular Journal of Africa. 2016; 27(2):1-5.

David A. Savitz J. Pregnancy-induced hypertension in North Carolina. American Journal of Public Health. 1992;82(5):675–679.

Joey P, Barbara T, Maria T, William A, Raouf A. Pathophysiology of hypertension during pre-eclampsia linking placental ischemia with endothelial dysfunction. Hypertension. 2001;38(1):718-722.

Young B, Levine R, Karumanchi S. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5(1):173‐192.

Chandrasekhar Y, Robert E. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of pre-eclampsia. American Journal of Obstetrics and Gynecology. 1993;165(5): 1316-1320.

Asfaw N, Storesund H, Skattebol L, Tonnesen F, Aasen A. Volatile oil constituents of twoThymus species from Ethiopia. Flavor and Fragrance Journal. 2000;15(1):123-125.

Abera T, Debebe E, Ashebir R, Abebe A, Basha H, Kasahun T. Phytochemical constituents, safety and efficacy study of Thymus schimperi and Thymus serrulatus. J Clin Exp Pharmacol. 2019; 10(1):263-267.

Haji H, Makonnen E, Debella A, Bekesho G. Evaluation of diuretic and anti-hypertensive activity of leaf extracts of Thymus schimperi in Rats. Ann Clin Lab Res. 2016;4(1):1-5.

Bekesho G, Mebrahtu E, Selamu K, Asfaw D, Eyasu M, Abiy A. In vitro vasodilatory effect of aqueous leaf extract of Thymus serrulatus on thoracic aorta of Guinea pigs. Asian Pac J Trop Biomed. 2015;5(1):15-19.

Mengistu A, Abebe Y, Mekonnen Y, Tolessa T. In vivo and in vitro hypotensive effect of aqueous extract of Moringa stenopetala. African Health Sciences. 2012;12(4):545-551.

Molnar S, Toth H. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombo-cytopenia, and intrauterine growth retardation. Am J Obstet Gynecol. 1994;170(5):1458-1466.

Podjarny E, Losonczy G, Baylis C. Animal models of preeclampsia. Semin Nephrol. 2004;24(6):596‐606.

Chang C, Su M, Ho J. The efficacy of semi-quantitative urine protein-to-creatinine (P/C) ratio for the detection of significant proteinuria in urine specimens in health screening settings. Springer Plus. 2016;5(1):1791-1798.

Siddiqui A, Jaleel A, Alkadri H, Akram S, Tamimi W. Biomarkers of oxidative stress in women with pre-eclampsia. Biomark Med. 2013;7(2):229-234.

Mutlu T, Ademoglu I, Aykaç U. Imbalance between Lipid Peroxidation and Anti-oxidant Status in Preeclampsia. Gynecol Obstet Invest. 1998;46(1):37-40.

Bekesho G, Eyasu M, Asfaw D, Ashenif T. In vivo antihypertensive and anti-hyperlipidemic effects of the crude extracts and fractions of Moringa stenopetala (Baker f.) Cufod. Leaves in Rats. Frontiers in Pharmacology. 2016;7(1):97-108.

Catherine M, Vesna D. Drug treatment of hypertension in pregnancy. Drugs. 2014; 74(3):283–296.